Revvity Price to Sales Ratio 2012-2026 | RVTY
Historical PS ratio values for Revvity (RVTY) over the last 10 years. The current P/S ratio for Revvity as of June 05, 2026 is .
| Revvity P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-06-08 | 100.30 | 3.96 | |
| 2026-03-31 | 87.54 | $25.36 | 3.45 |
| 2025-12-31 | 96.62 | $24.53 | 3.94 |
| 2025-09-30 | 87.46 | $23.65 | 3.70 |
| 2025-06-30 | 96.44 | $23.16 | 4.16 |
| 2025-03-31 | 105.42 | $22.63 | 4.66 |
| 2024-12-31 | 111.14 | $22.36 | 4.97 |
| 2024-09-30 | 127.14 | $22.00 | 5.78 |
| 2024-06-30 | 104.29 | $21.84 | 4.78 |
| 2024-03-31 | 104.36 | $21.89 | 4.77 |
| 2023-12-31 | 108.57 | $21.97 | 4.94 |
| 2023-09-30 | 109.88 | $22.25 | 4.94 |
| 2023-06-30 | 117.84 | $22.48 | 5.24 |
| 2023-03-31 | 132.13 | $23.90 | 5.53 |
| 2022-12-31 | 138.95 | $26.17 | 5.31 |
| 2022-09-30 | 119.18 | $24.00 | 4.97 |
| 2022-06-30 | 140.79 | $25.86 | 5.44 |
| 2022-03-31 | 172.63 | $29.71 | 5.81 |
| 2021-12-31 | 198.87 | $33.73 | 5.90 |
| 2021-09-30 | 171.34 | $32.14 | 5.33 |
| 2021-06-30 | 152.60 | $33.23 | 4.59 |
| 2021-03-31 | 126.72 | $29.56 | 4.29 |
| 2020-12-31 | 141.68 | $23.78 | 5.96 |
| 2020-09-30 | 123.84 | $28.91 | 4.28 |
| 2020-06-30 | 96.73 | $26.66 | 3.63 |
| 2020-03-31 | 74.17 | $25.88 | 2.87 |
| 2019-12-31 | 95.60 | $25.87 | 3.70 |
| 2019-09-30 | 83.78 | $25.43 | 3.30 |
| 2019-06-30 | 94.70 | $25.12 | 3.77 |
| 2019-03-31 | 94.65 | $24.96 | 3.79 |
| 2018-12-31 | 77.09 | $24.91 | 3.09 |
| 2018-09-30 | 95.39 | $23.92 | 3.99 |
| 2018-06-30 | 71.75 | $22.88 | 3.14 |
| 2018-03-31 | 74.12 | $21.50 | 3.45 |
| 2017-12-31 | 71.51 | $20.38 | 3.51 |
| 2017-09-30 | 67.39 | $19.73 | 3.41 |
| 2017-06-30 | 66.51 | $19.41 | 3.43 |
| 2017-03-31 | 56.60 | $19.36 | 2.92 |
| 2016-12-31 | 50.77 | $19.17 | 2.65 |
| 2016-09-30 | 54.56 | $18.01 | 3.03 |
| 2016-06-30 | 50.90 | $18.30 | 2.78 |
| 2016-03-31 | 47.96 | $18.38 | 2.61 |
| 2015-12-31 | 51.87 | $18.54 | 2.80 |
| 2015-09-30 | 44.44 | $18.44 | 2.41 |
| 2015-06-30 | 50.83 | $18.24 | 2.79 |
| 2015-03-31 | 49.31 | $18.17 | 2.71 |
| 2014-12-31 | 42.10 | $18.19 | 2.31 |
| 2014-09-30 | 41.90 | $19.50 | 2.15 |
| 2014-06-30 | 44.95 | $19.35 | 2.32 |
| 2014-03-31 | 43.17 | $19.27 | 2.24 |
| 2013-12-31 | 39.44 | $19.01 | 2.07 |
| 2013-09-30 | 36.04 | $18.72 | 1.93 |
| 2013-06-30 | 30.96 | $18.53 | 1.67 |
| 2013-03-31 | 31.98 | $18.29 | 1.75 |
| 2012-12-31 | 30.11 | $18.36 | 1.64 |
| 2012-09-30 | 27.90 | $18.20 | 1.53 |
| 2012-06-30 | 24.35 | $17.76 | 1.37 |
| 2012-03-31 | 26.04 | $17.42 | 1.49 |
| 2011-12-31 | 18.77 | $16.83 | 1.12 |
| 2011-09-30 | 17.96 | $16.05 | 1.12 |
| 2011-06-30 | 25.10 | $15.61 | 1.61 |
| 2011-03-31 | 24.43 | $14.95 | 1.63 |
| 2010-12-31 | 23.95 | $14.41 | 1.66 |
| 2010-09-30 | 21.40 | $13.02 | 1.64 |
| 2010-06-30 | 19.04 | $12.71 | 1.50 |
| 2010-03-31 | 21.96 | $12.92 | 1.70 |
| 2009-12-31 | 18.85 | $13.31 | 1.42 |
| 2009-09-30 | 17.56 | $12.57 | 1.40 |
| 2009-06-30 | 15.81 | $13.34 | 1.19 |
| 2009-03-31 | 11.55 | $13.80 | 0.84 |
| 2008-12-31 | 12.51 | $13.94 | 0.90 |
| 2008-09-30 | 22.40 | $15.87 | 1.41 |
| 2008-06-30 | 24.91 | $15.51 | 1.61 |
| 2008-03-31 | 21.63 | $14.90 | 1.45 |
| 2007-12-31 | 23.15 | $14.30 | 1.62 |
| 2007-09-30 | 25.92 | $13.37 | 1.94 |
| 2007-06-30 | 23.07 | $12.82 | 1.80 |
| 2007-03-31 | 21.38 | $12.15 | 1.76 |
| 2006-12-31 | 19.56 | $11.62 | 1.68 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.039B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |